retatrutide trials results Results: 28.3% Weight Loss Data Eli Lilly's Retatrutide Phase 3
Description
Other documented adverse effects include decreased appetite (which contributes to the therapeutic effect), fatigue, injection site reactions, dizziness, and modest increases in heart rate (typically 2-4 beats per minute)
Journal Diabetes Investigation, 11 ,
Lancet 2014;384:13491357
Hydration helps with fullness and can prevent you from mistaking thirst for hunger
1 Tirzepatide, which acts on both the GIP and GLP-1 systems, also substantially cuts appetite and food intake
